Drugs: adverse reactions

You have access
COX-2 inhibitors in the treatment of cardiovascular disease
John C. Peterson

CMAJ October 01, 2002 167 (7) 738-739;
You have access
COX-2 inhibitors in the treatment of cardiovascular disease
Ann Sztuke-Fournier and Marielle McMorran

CMAJ October 01, 2002 167 (7) 739-740;
You have access
COX-2 inhibitors in the treatment of cardiovascular disease
Jean-Pierre Raynauld

CMAJ October 01, 2002 167 (7) 739;
You have access
Erythematous eruption in a man with acute myeloid leukemia
Jason Tay

CMAJ September 17, 2002 167 (6) 672-673;
You have access
Drug safety without borders: concerns about bupropion
Barbara Mintzes, Ken Bassett and James M. Wright

CMAJ September 03, 2002 167 (5) 447;
You have access
Low-dose droperidol
Greg Allen

CMAJ September 03, 2002 167 (5) 452-452-a;
You have access
Low-dose droperidol
Eric Wooltorton

CMAJ September 03, 2002 167 (5) 452-452-b;
You have access
Propofol: contraindicated for sedation of pediatric intensive care patients
Eric Wooltorton

CMAJ September 03, 2002 167 (5) 507;
You have access
Grapefruit juice: potential drug interactions
James Maskalyk

CMAJ August 06, 2002 167 (3) 279-280;
You have access
Adverse events associated with pyrazinamide and levofloxacin in the treatment of latent multidrug-resistant tuberculosis
Tina Papastavros, Lisa R. Dolovich, Anne Holbrook, Lori Whitehead and Mark Loeb

CMAJ July 23, 2002 167 (2) 131-136;

Main menu